Literature DB >> 17229304

QT interval correction in patients with cirrhosis.

Andrea Zambruni1, Antonio Di Micoli, Alessandro Lubisco, Marco Domenicali, Franco Trevisani, Mauro Bernardi.   

Abstract

INTRODUCTION: QT interval prolongation is a common electrophysiological abnormality in patients with cirrhosis. As QT interval varies with the heart rate, many QT correction formulas have been proposed, the Bazett's one being the most criticized because it over-corrects the QT interval and may be misleading. This study focused on the QT-RR relationship in patients with cirrhosis to derive a population-specific QT correction formula.
METHODS: One hundred cirrhotic patients of different etiology and severity and 53 healthy controls comparable for age and sex were enrolled. The QT-RR relationship was analyzed in patients by five regression analysis models to derive the population-specific QT-RR equation. The QTc was calculated and compared with those calculated by four common QT correction formulas (Bazett, Fridericia, Framingham, and Hodges). The correlation coefficient QTc-RR was calculated as a measure of the independence of QTc from the original RR interval.
RESULTS: In patients the QT-RR relationship was best described by the power equation "QT = 453.65 x RR1/3.02" (R2 = 0.41), similar to the Fridericia's formula. Bazett's formula led to the longest QTc (P < 0.0001), which was still significantly influenced by the RR interval (R = -0.39; P < 0.0001), while the estimated equation led to a QTc value not influenced by RR (R = -0.014).
CONCLUSION: Bazett's correction should be avoided in patients with cirrhosis because it still provides a rate-dependent QTc value and might be misleading, particularly when assessing the overall preoperative cardiac risk and the effect of drugs affecting the QT interval. In its place, our formula or that of Fridericia can be confidently employed.

Entities:  

Mesh:

Year:  2007        PMID: 17229304     DOI: 10.1111/j.1540-8167.2006.00622.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  19 in total

Review 1.  The Art and Science of Diagnosing and Treating Lung and Heart Disease Secondary to Liver Disease.

Authors:  David S Goldberg; Michael B Fallon
Journal:  Clin Gastroenterol Hepatol       Date:  2015-04-28       Impact factor: 11.382

2.  QT interval prolongation in end-stage liver disease cannot be explained by nonhepatic factors.

Authors:  Divyang Patel; Prabhpreet Singh; William Katz; Christopher Hughes; Kapil Chopra; Jan Němec
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-04-24       Impact factor: 1.468

3.  Terlipressin infusion induces Tako-Tsubo syndrome in a cirrhotic man with hepato-renal syndrome.

Authors:  Antonio Di Micoli; Daniela Buccione; Daniela Degli Esposti; Valentina Santi; Luciana Bastagli; Claudio Borghi; Mauro Bernardi; Franco Trevisani
Journal:  Intern Emerg Med       Date:  2011-02-15       Impact factor: 3.397

4.  Prevalence and clinical presentation of cirrhotic cardiomyopathy: A single centre experience from southern India.

Authors:  Ravi Bokarvadia; Mayank Jain; Chandankumar Kedarisetty; Joy Varghese; Jayanthi Venkataraman
Journal:  Indian J Gastroenterol       Date:  2019-05-21

5.  Hepatobiliary Quiz (Answers)-16 (2015).

Authors:  Sahaj Rathi; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2015-12-21

6.  Cardiac abnormalities in cirrhotic children: pre- and post-liver transplantation.

Authors:  Khemika Khemakanok; Anant Khositseth; Suporn Treepongkaruna; Sumate Teeraratkul; Wichai Pansrimangkorn; Surasak Leelaudomlipi; Uthen Bunmee; Suthus Sriphojanart
Journal:  Hepatol Int       Date:  2015-10-13       Impact factor: 6.047

7.  Cardiac remodelling identified by cardiovascular magnetic resonance in patients with hepatitis C infection and liver disease.

Authors:  Phillip J Ngu; Michelle Butler; Alan Pham; Stuart K Roberts; Andrew J Taylor
Journal:  Int J Cardiovasc Imaging       Date:  2015-12-15       Impact factor: 2.357

Review 8.  Diastolic dysfunction in cirrhosis.

Authors:  Søren Møller; Signe Wiese; Hanne Halgreen; Jens D Hove
Journal:  Heart Fail Rev       Date:  2016-09       Impact factor: 4.214

Review 9.  Cirrhotic cardiomyopathy.

Authors:  Luis Ruiz-del-Árbol; Regina Serradilla
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

10.  Relationship between QT interval prolongation and structural abnormalities in cirrhotic cardiomyopathy: A change in the current paradigm.

Authors:  Anoop N Koshy; Paul J Gow; Adam Testro; Andrew W Teh; Jefferson Ko; Han S Lim; Hui-Chen Han; Laurence Weinberg; Lisa B VanWagner; Omar Farouque
Journal:  Am J Transplant       Date:  2021-02-08       Impact factor: 9.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.